|
Order Kazusa clone(s) from : |
| Accession No | |
|---|---|
| Product ID | ORK01936 |
| Clone name | ph01207 |
| Vector information | |
| Symbol | ADGRB2 |
| cDNA sequence | DNA sequence (5119 bp) Predicted protein sequence (1547 aa) |
|
HaloTag ORF Clone |
FHC01936
|
| Flexi ORF Clone | FXC01936 |
| Description | Brain-specific angiogenesis inhibitor 2 precursor. |
Length: 5119 bp
Physical map
Restriction map
Prediction of protein coding region (GeneMark analysis) for :
cloned DNA seq.
Warning for N-terminal truncation: NO
Warning for coding interruption : NO
Integrity of 3' end
| Length of 3'UTR | 302 bp |
|---|---|
| Genome contig ID | gi89161185r_31865353 |
| PolyA signal sequence (AATAAA,-19) |
+----*----+----*----+----*----+---- |
| Flanking genome sequence (99953 - 99904) |
----+----*----+----*----+----*----+----*----+----* |
Length: 1547 aa
Result of homology search against nr database
(FASTA output,
Multiple alignment)![]() |
|
The numbers on the left and right sides of a black line in the graphical overview indicate the lengths (in amino acid residues) of the non-homologous N-terminal and C-terminal portions flanking the homologous region (indicated by the black line), respectively.
Result of motif / domain search (InterProScan and SOSUI)
Result of InterProScan
| Search method | interpro_ID | From | To | Entry | Definition |
|---|---|---|---|---|---|
| FPrintScan | IPR008077 | 82 | 99 | PR01694 | Brain-specific angiogenesis inhibitor |
| IPR008077 | 519 | 531 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR008077 | 539 | 555 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR008077 | 596 | 615 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR008077 | 638 | 647 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR008077 | 699 | 720 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR000832 | 896 | 920 | PR00249 | GPCR | |
| IPR008077 | 920 | 930 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR000832 | 960 | 983 | PR00249 | GPCR | |
| IPR008077 | 984 | 997 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR000832 | 997 | 1022 | PR00249 | GPCR | |
| IPR008077 | 1023 | 1040 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR000832 | 1040 | 1065 | PR00249 | GPCR | |
| IPR000832 | 1115 | 1135 | PR00249 | GPCR | |
| IPR008077 | 1136 | 1146 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR000832 | 1146 | 1167 | PR00249 | GPCR | |
| IPR008077 | 1200 | 1213 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR008077 | 1420 | 1434 | PR01694 | Brain-specific angiogenesis inhibitor | |
| IPR008077 | 1437 | 1451 | PR01694 | Brain-specific angiogenesis inhibitor | |
| HMMPfam | IPR000884 | 330 | 378 | PF00090 | Thrombospondin |
| IPR000884 | 385 | 433 | PF00090 | Thrombospondin | |
| IPR000884 | 441 | 489 | PF00090 | Thrombospondin | |
| IPR001879 | 493 | 554 | PF02793 | Hormone receptor | |
| IPR000203 | 832 | 880 | PF01825 | GPS | |
| IPR000832 | 891 | 1171 | PF00002 | GPCR | |
| HMMSmart | IPR000884 | 329 | 379 | SM00209 | Thrombospondin |
| IPR000884 | 384 | 434 | SM00209 | Thrombospondin | |
| IPR000884 | 440 | 490 | SM00209 | Thrombospondin | |
| IPR001879 | 492 | 558 | SM00008 | Hormone receptor | |
| IPR000203 | 832 | 885 | SM00303 | GPS | |
| ProfileScan | IPR000884 | 326 | 379 | PS50092 | Thrombospondin |
| IPR000884 | 381 | 434 | PS50092 | Thrombospondin | |
| IPR000884 | 437 | 490 | PS50092 | Thrombospondin | |
| IPR001879 | 483 | 553 | PS50227 | Hormone receptor | |
| IPR000203 | 833 | 885 | PS50221 | GPS | |
| IPR000832 | 894 | 1168 | PS50261 | GPCR |
Prediction of transmembrane (TM) segments| Method | No. | N terminal | transmembrane region | C terminal | type | length | SOSUI2 | 1 | 29 | RMTPACPLLLSVILSLRLATAFD | 51 | SECONDARY | 23 | 2 | 774 | SYFVIGAVLYRTLGLILPPP | 793 | SECONDARY | 20 | 3 | 897 | PLVIGCAVSCMALLTLLAIYAAF | 919 | PRIMARY | 23 | 4 | 930 | ILLNFCLSILASNILILVGQSRV | 952 | PRIMARY | 23 | 5 | 963 | AFLHFFFLSSFCWVLTEAWQSYL | 985 | SECONDARY | 23 | 6 | 1000 | FLCLGWGLPALVVAVSVG | 1017 | SECONDARY | 18 | 7 | 1039 | LYAFVGPAAVIVLVNMLIGIIVF | 1061 | PRIMARY | 23 | 8 | 1085 | PWASLLLPCSACGAVPSPLLSSA | 1107 | SECONDARY | 23 | 9 | 1116 | LWSSCVVLPLLALTWMSAVLAMT | 1138 | PRIMARY | 23 | 10 | 1143 | VLFQALFAVFNSAQGFVITAVHC | 1165 | SECONDARY | 23 |
|---|